ストックスクリーナーアプリを入手
177.87
0.31%
0.55
アフターアワーズ：
177.87
前日終値:
$177.32
開ける：
$177.85
24時間の取引高:
1.33M
Relative Volume:
0.84
時価総額：
$9.29B
収益：
$1.53B
当期純損益:
$207.70M
株価収益率:
-64.13
EPS:
-2.7734
ネットキャッシュフロー:
$193.10M
1週間 パフォーマンス:
-0.46%
1か月 パフォーマンス:
+1.44%
6か月 パフォーマンス:
+20.55%
1年 パフォーマンス:
+6.76%
1日の値動き範囲:
$176.94
$178.21
1週間の範囲:
$176.68
$178.77
52週間の値動き範囲:
$125.94
$179.00
Masimo Corp Stock (MASI) Company Profile
Compare MASI vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
177.87 | 9.26B | 1.53B | 207.70M | 193.10M | -2.7734 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-27 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2025-11-17 | 開始されました | BofA Securities | Neutral |
| 2024-12-27 | 繰り返されました | Raymond James | Outperform |
| 2024-11-06 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2024-06-03 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-04-15 | アップグレード | Stifel | Hold → Buy |
| 2024-03-25 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | ダウングレード | Jefferies | Buy → Hold |
| 2024-01-03 | ダウングレード | Needham | Buy → Hold |
| 2023-11-08 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-07-18 | ダウングレード | Stifel | Buy → Hold |
| 2023-07-10 | 開始されました | Wells Fargo | Equal Weight |
| 2023-02-22 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2022-12-15 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-12-05 | 繰り返されました | Needham | Buy |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-09-15 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2022-09-14 | 開始されました | Loop Capital | Buy |
| 2022-04-06 | 開始されました | Wolfe Research | Peer Perform |
| 2022-02-18 | アップグレード | Needham | Hold → Buy |
| 2022-02-16 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-10-12 | 再開されました | Raymond James | Mkt Perform |
| 2020-09-02 | 開始されました | Robert W. Baird | Outperform |
| 2020-08-14 | 再開されました | Piper Sandler | Overweight |
| 2020-04-20 | ダウングレード | Needham | Buy → Hold |
| 2020-03-02 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2019-05-07 | 繰り返されました | Needham | Buy |
| 2019-04-16 | ダウングレード | BTIG Research | Buy → Neutral |
| 2019-03-13 | 繰り返されました | Needham | Buy |
| 2018-12-19 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2018-09-14 | 開始されました | Needham | Buy |
| 2018-03-09 | 開始されました | Barclays | Overweight |
| 2017-08-14 | アップグレード | BTIG Research | Neutral → Buy |
| 2017-04-04 | 繰り返されました | Wedbush | Outperform |
| 2017-03-16 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2017-02-27 | 繰り返されました | Wedbush | Outperform |
| 2017-02-13 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2016-08-04 | 繰り返されました | Wedbush | Outperform |
| 2016-05-05 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2016-05-05 | 繰り返されました | Wedbush | Outperform |
| 2016-01-06 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2015-08-05 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Masimo Corp (MASI) 最新ニュース
Quinn Emanuel disqualified in Masimo board dispute - Daily Journal
Quinn Emanuel Disqualified from Masimo Board Fight with Founder - Bloomberg Law News
Masimo Corp Stock: Innovative Medical Tech Leader with Strong Growth Potential for North American In - AD HOC NEWS
Assenagon Asset Management S.A. Grows Stock Holdings in Masimo Corporation $MASI - MarketBeat
Masimo Corporation (NASDAQ:MASI) Short Interest Update - MarketBeat
Masimo Corp at JPMorgan Healthcare Conference Transcript - GuruFocus
Masimo Corp Stock Faces Uncertainty Amid Analyst Downgrade and Pending Danaher Acquisition Deal - AD HOC NEWS
Danaher to Acquire Masimo Diagnostics in $9.9B Deal - USA Herald
The Vanguard Group discloses 0 shares in Masimo Corp (NASDAQ: MASI) - Stock Titan
Masimo downgraded to Market Perform from Outperform at Raymond James - TipRanks
Masimo (NASDAQ:MASI) Rating Lowered to Market Perform at Raymond James Financial - MarketBeat
Raymond James downgrades Masimo stock rating on Danaher deal By Investing.com - Investing.com India
Masimo Corporation $MASI Shares Sold by JPMorgan Chase & Co. - MarketBeat
Raymond James downgrades Masimo stock rating on Danaher deal - Investing.com
Masimo Corporation (NASDAQ:MASI) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
MASI PE Ratio & Valuation, Is MASI Overvalued - Intellectia AI
Tudor Investment Corp ET AL Buys New Holdings in Masimo Corporation $MASI - MarketBeat
Masimo MightySat Medical Fingertip Pulse Oximeter: Precision Health Monitoring for Home and Clinical - AD HOC NEWS
Danaher said to near $10 billion deal for Masimo, FT reports - MSN
Masimo (NASDAQ:MASI) Reaches New 12-Month HighTime to Buy? - MarketBeat
This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition - Yahoo Finance
This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition - The Motley Fool
Masimo's Patient Monitoring Innovations Drive Growth in Wearable Health Tech for DACH Markets - AD HOC NEWS
Masimo's Latest Health Monitoring Receivers Advance Wearable Audio Integration for DACH Consumers - AD HOC NEWS
MASI Technical Analysis & Stock Price Forecast - Intellectia AI
Apple fends off bid for new Apple Watch import ban at US trade tribunal - Reuters
Masimo (NASDAQ:MASI) Upgraded at Wells Fargo & Company - MarketBeat
Apple Took Masimo IP But No Remedy Warranted, Judge Says - Law360
Danaher to buy Masimo (MASI) for $180 a share; $305M breakup fee - Stock Titan
Masimo (NASDAQ:MASI) Sets New 52-Week HighShould You Buy? - MarketBeat
Masimo Corporation stock hits 52-week high at $175.91 - Investing.com
Masimo Corporation stock hits 52-week high at $175.91 By Investing.com - Investing.com Canada
Masimo (NASDAQ:MASI) Sees Large Volume IncreaseTime to Buy? - MarketBeat
Danaher to acquire Irvine-based Masimo - Irvine Standard
Masimo (MASI) CFO exercises RSUs, retains shares after tax withholding - Stock Titan
Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders? – Company Announcement - Financial Times
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement - Yahoo Finance
Masimo Corporation $MASI Shares Purchased by Squarepoint Ops LLC - MarketBeat
Onex Canada Asset Management Inc. Has $4.12 Million Stake in Masimo Corporation $MASI - MarketBeat
Danaher Corp to acquire Masimo for $9.9B - respiratory-therapy.com
Politan-linked funds structure MASIMO (MASI) forward sales over 273,550 shares - Stock Titan
12,025 Shares in Masimo Corporation $MASI Bought by Quantitative Investment Management LLC - MarketBeat
Danaher Corp. Stock (ISIN: US2358511028) Slides Amid Masimo Acquisition Scrutiny and Conservative Gu - AD HOC NEWS
Danaher Corp Stock (DHR) Moved Down by 3.55% on Mar 12: Drivers Behind the Movement - TradingKey
MASI SEC FilingsMasimo Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Schroder Investment Management Group Has $48.12 Million Holdings in Masimo Corporation $MASI - MarketBeat
Masimo (MASI) Chief Commercial Officer granted 8,550 RSUs in new Form 4 - Stock Titan
Masimo (MASI) grants Chief Marketing Officer 6,128 RSUs vesting over four years - Stock Titan
Masimo (MASI) grants 5,985 restricted stock units to Chief HR Officer - Stock Titan
Masimo (MASI) awards EVP of Operations 6,840 restricted stock units - Stock Titan
Masimo (NASDAQ: MASI) CFO gets 17,671 RSUs vesting over 4 years - Stock Titan
Masimo Corp (MASI) 財務データ
収益
当期純利益
現金流量
EPS
2.03%
大文字化:
|
ボリューム (24 時間):